Glycemic control in diabetic kidney disease patients

Jha, 2009, Current status of chronic kidney disease care in southeast Asia, Semin Nephrol, 29, 487, 10.1016/j.semnephrol.2009.06.005 Dirks JH, de Zeeuw D, Agarwal SK, et al. Prevention of chronic kidney and vascular disease: toward global health equity: the Bellagio 2004 Declaration. Parving, 1988, Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes, Br Med J (Clin Res Ed), 296, 156, 10.1136/bmj.296.6616.156 Standl, 1993, Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the greater Munich area, Diabetologia, 36, 1017, 10.1007/BF02374493 Schmitz, 1994, Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM, Diabetologia, 37, 1251, 10.1007/BF00399799 Yale, 2005, Oral antihyperglycemic agents and renal disease: new agents, new concepts, J Am Soc Nephrol, 16, S7, 10.1681/ASN.2004110974 Kovesdy, 2008, Glycemic control in diabetic CKD patients: where do we stand?, Am J Kidney Dis, 52, 766, 10.1053/j.ajkd.2008.04.011 UK Prospective Diabetes Study (UKPDS) Group, 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 Mogensen, 1984, Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes, N Engl J Med, 310, 356, 10.1056/NEJM198402093100605 Rossing, 2006, Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005, Diabetologia, 49, 11, 10.1007/s00125-005-0077-3 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus: The Diabetes Control and Complications Trial Research Group, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 Morioka, 2001, Glycemic control is a predictor of survival for diabetic patients on hemodialysis, Diabetes Care, 24, 909, 10.2337/diacare.24.5.909 Ansari, 2003, Assessing glycemic control in patients with diabetes and end-stage renal failure, Am J Kidney Dis, 41, 523, 10.1053/ajkd.2003.50114 2007, National Kidney Foundation: KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease, Am J Kidney Dis, 49, S1, 10.1053/S0272-6386(07)00160-6 American Diabetes Association, 2012, Standards of medical care in diabetes, 2012, Diabetes Care, 35, S11 Morgan, 1996, Glycated proteins as indices of glycaemic control in diabetic patients with chronic renal failure, Diabet Med, 13, 514, 10.1002/(SICI)1096-9136(199606)13:6<514::AID-DIA108>3.0.CO;2-4 Joy, 2002, Long-term glycemic control measurements in diabetic patients receiving hemodialysis, Am J Kidney Dis, 39, 297, 10.1053/ajkd.2002.30549 Tzamaloukas, 1998, The use of glycosylated hemoglobin in dialysis patients, Semin Dial, 11, 143 Shichiri, 2000, Longterm results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients, Diabetes Care, 23, B21 Nathan, 2009, Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes, Diabetes Care, 32, 193, 10.2337/dc08-9025 Kramer, 2005, Screening for kidney disease in adults with diabetes, Diabetes Care, 28, 1813, 10.2337/diacare.28.7.1813 Moen, 2009, Frequency of hypoglycemia and its significance in chronic kidney disease, Clin J Am Soc Nephrol, 4, 1121, 10.2215/CJN.00800209 Wolf, 2003, Diabetic nephropathy in type 2 diabetes prevention and patient management, J Am Soc Nephrol, 14, 1396, 10.1097/01.ASN.0000065639.19190.CF Nagai, 2003, Hypoglycemia due to nateglinide administration in diabetic patient with chronic renal failure, Diabetes Res Clin Pract, 59, 191, 10.1016/S0168-8227(02)00242-5 Snyder, 2004, Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease, Semin Dial, 17, 365, 10.1111/j.0894-0959.2004.17346.x Nesto, 2004, Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association, Diabetes Care, 27, 256, 10.2337/diacare.27.1.256 Meier, 2004, Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects, Diabetes, 53, 654, 10.2337/diabetes.53.3.654 Heise, 2009, Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients, Diabetes Obes Metab, 11, 786, 10.1111/j.1463-1326.2009.01046.x Rabkin, 1984, The renal metabolism of insulin, Diabetologia, 27, 351, 10.1007/BF00304849 Mak, 1992, Glucose and insulin metabolism in uremia, Nephron, 61, 377, 10.1159/000186953 Adrogu, 1992, Glucose homeostasis and the kidney, Kidney Int, 42, 1266, 10.1038/ki.1992.414 Freeman, 1991, Use of human ultralente as the basal insulin component in treatment of patients with IDDM, Diabetes Res Clin Pract, 12, 187, 10.1016/0168-8227(91)90076-P Charpentier, 2000, Management of drugs affecting blood glucose in diabetic patients with renal failure, Diabetes Metab, 26, 73 Ohkubo, 1995, Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study, Diabetes Res Clin Pract, 28, 103, 10.1016/0168-8227(95)01064-K Mak, 2000, Impact of end-stage renal disease and dialysis on glycemic control, Semin Dial, 13, 4, 10.1046/j.1525-139x.2000.00007.x Nevalainen, 1999, The effect of insulin delivery route on lipoproteins in type I diabetic patients on CAPD, Perit Dial Int, 19, 148, 10.1177/089686089901900213 Arem, 1989, Hypoglycemia associated with renal failure, Endocrinol Metab Clin North Am, 18, 103, 10.1016/S0889-8529(18)30391-8